Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The role of evidence in consumer choice of non-prescription medicines.

Bevan M, Ng YC, Cooper J, Robertson J, Walkom E, Chiu S, Newby DA.

Int J Pharm Pract. 2019 Dec;27(6):501-509. doi: 10.1111/ijpp.12546. Epub 2019 May 29.

PMID:
31140669
2.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

3.

Assessing medication packaging and labelling appropriateness in Sri Lanka.

Athuraliya N, Walkom EJ, Dharmaratne S, Robertson J.

J Pharm Policy Pract. 2016 Nov 25;9:38. eCollection 2016.

4.

Health Care Spending: Changes in the Perceptions of the Australian Public.

Robertson J, Newby DA, Walkom EJ.

PLoS One. 2016 Jun 13;11(6):e0157312. doi: 10.1371/journal.pone.0157312. eCollection 2016.

5.

Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis.

Ren S, Newby D, Li SC, Walkom E, Miller P, Hure A, Attia J.

Open Heart. 2015 Jun 26;2(1):e000247. doi: 10.1136/openhrt-2015-000247. eCollection 2015. Review.

6.

Costs of medicines and health care: a concern for Australian women across the ages.

Walkom EJ, Loxton D, Robertson J.

BMC Health Serv Res. 2013 Nov 20;13:484. doi: 10.1186/1472-6963-13-484.

7.

Medicines and the media: news reports of medicines recommended for government reimbursement in Australia.

Robertson J, Walkom EJ, Bevan MD, Newby DA.

BMC Public Health. 2013 May 21;13:489. doi: 10.1186/1471-2458-13-489.

8.

Health systems and sustainability: doctors and consumers differ on threats and solutions.

Robertson J, Walkom EJ, Henry DA.

PLoS One. 2011 Apr 27;6(4):e19222. doi: 10.1371/journal.pone.0019222.

9.
10.

The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature.

Robertson J, Walkom E, Pearson SA, Hains I, Williamsone M, Newby D.

Int J Pharm Pract. 2010 Apr;18(2):69-87. Review.

PMID:
20441116
11.

Mandatory disclosure of pharmaceutical industry-funded events for health professionals.

Robertson J, Moynihan R, Walkom E, Bero L, Henry D.

PLoS Med. 2009 Nov;6(11):e1000128. doi: 10.1371/journal.pmed.1000128. Epub 2009 Nov 3. No abstract available.

12.

Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.

Robertson J, Walkom EJ, Henry DA.

Aust Health Rev. 2009 May;33(2):192-9.

PMID:
19563308
13.

The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994-2004.

Harris AH, Hill SR, Chin G, Li JJ, Walkom E.

Med Decis Making. 2008 Sep-Oct;28(5):713-22. doi: 10.1177/0272989X08315247. Epub 2008 Mar 31.

PMID:
18378939
14.

An evaluation of the World Health Organization problem-based pharmacotherapy teaching courses (based on the "Guide to Good Prescribing"), 1994-2001.

Smith A, Hill S, Walkom E, Thambiran M.

Eur J Clin Pharmacol. 2005 Nov;61(10):785-6. Epub 2005 Sep 21. No abstract available.

PMID:
16187131
15.

Response rates and representativeness: a lottery incentive improves physician survey return rates.

Robertson J, Walkom EJ, McGettigan P.

Pharmacoepidemiol Drug Saf. 2005 Aug;14(8):571-7.

PMID:
15937989

Supplemental Content

Loading ...
Support Center